Second-tier test for quantification of alloisoleucine and branched-chain amino acids in dried blood spots to improve newborn screening for maple syrup urine disease (MSUD).
about
Principles and applications of liquid chromatography-mass spectrometry in clinical biochemistryNewborn screening.Postanalytical tools improve performance of newborn screening by tandem mass spectrometry.Rapid and precise measurement of serum branched-chain and aromatic amino acids by isotope dilution liquid chromatography tandem mass spectrometry.A novel freeze-dried storage and preparation method for the determination of mycophenolic acid in plasma by high-performance liquid chromatography.Dried blood spot proteomics: surface extraction of endogenous proteins coupled with automated sample preparation and mass spectrometry analysis.Adipose transplant for inborn errors of branched chain amino acid metabolism in mice.Newborn screening and renal disease: where we have been; where we are now; where we are going.Inborn errors of metabolism and expanded newborn screening: review and update.Dried blood spots: concepts, present status, and future perspectives in bioanalysis.The use of mass spectrometry to analyze dried blood spots.Expanded newborn screening by mass spectrometry: New tests, future perspectives.Alloisoleucine differentiates the branched-chain aminoacidemia of Zucker and dietary obese ratsMaple syrup urine disease: mechanisms and management.Newborn screening for dihydrolipoamide dehydrogenase deficiency: Citrulline as a useful analyte.Progress in expanded newborn screening for metabolic conditions by LC-MS/MS in Tuscany: update on methods to reduce false tests.Measurement of plasma amino acids by Ultraperformance® Liquid Chromatography.Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: a worldwide collaborative project.Targeted metabolomics in the expanded newborn screening for inborn errors of metabolismDisorders of branched chain amino acid metabolism.Integrated Multianalyte Second-Tier Testing for Newborn Screening for MSUD, IVA, and GAMT DeficienciesGenetic cause and prevalence of hydroxyprolinemia
P2860
Q24653004-BE184DF8-70CD-4465-B769-13345DA2ED02Q33868506-53D1AB50-2ADE-4FC3-9D18-D35A966DBA40Q34675169-30C89C14-88E7-4E62-BB34-379DE29ED8A1Q35067425-5CBA0BB8-5178-41A2-B4B0-FD52F6E13AFFQ36282140-AAE2ECA1-5B94-4425-BA3E-99CB760D2669Q37018712-1ECD8385-128A-4B3F-82F7-C781C7DC3820Q37640465-CB432DD2-AC70-4DE0-B494-9D09C17D3B59Q37938722-406987C0-65CC-497D-91FC-EA65B85A773BQ38167824-427DD4AF-C174-45EA-97BE-4014873EBA53Q38201371-F41C2EEE-B738-4F22-98CD-EC7681D669EFQ38253959-A26CA8C4-BC11-4CDC-801C-EE9D627813AAQ38465134-F06AF51D-AAF3-4832-B90E-59888210A4C9Q39179587-09EEA8C3-65F9-4205-AB67-0C8FBC5ED475Q41355931-F6D50E97-C37D-4C9F-865D-90C6670A9EFBQ41962400-EE18CD27-5438-4B79-956B-887F91D258A5Q46290639-40911F14-82C7-40B9-B150-3802950AFE00Q53086147-C785C40B-A7FA-43FF-896F-290EFBDA8BEEQ53438013-E14324FA-0103-4C67-A011-E87C178CB3EDQ53466033-54325B1B-4742-407B-A0CE-B1943B6D7FEDQ54966951-3779ECF2-63B3-42F4-9184-59A4B849FB1CQ56856036-6ACD9BF1-CC73-43A9-A4DF-4E213E026EEBQ57987662-2E6D55BA-A3E1-44F4-B091-09DFD2CB7DE5
P2860
Second-tier test for quantification of alloisoleucine and branched-chain amino acids in dried blood spots to improve newborn screening for maple syrup urine disease (MSUD).
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Second-tier test for quantific ...... le syrup urine disease (MSUD).
@en
Second-tier test for quantific ...... for maple syrup urine disease
@nl
type
label
Second-tier test for quantific ...... le syrup urine disease (MSUD).
@en
Second-tier test for quantific ...... for maple syrup urine disease
@nl
prefLabel
Second-tier test for quantific ...... le syrup urine disease (MSUD).
@en
Second-tier test for quantific ...... for maple syrup urine disease
@nl
P2093
P1433
P1476
Second-tier test for quantific ...... le syrup urine disease (MSUD).
@en
P2093
Bruno Casetta
Devin Oglesbee
Dietrich Matern
Jean M Lacey
Karen A Sanders
Kevin A Strauss
Mark J Magera
Piero Rinaldo
Silvia Tortorelli
P304
P356
10.1373/CLINCHEM.2007.098434
P407
P577
2008-01-04T00:00:00Z